MedCity Influencers

Dr. David Albert’s roller coaster ride in developing the iPhone ECG app

Close your eyes and imagine the scene with me. You’re at Grandma Betty’s house for a family gathering. Suddenly, Grandma Betty begins to experience chest pain. She’s had some issues with her heart in the past. But could this be it? Could Grandma Betty really be having a heart attack? Your normal reaction would be […]

Close your eyes and imagine the scene with me. You’re at Grandma Betty’s house for a family gathering. Suddenly, Grandma Betty begins to experience chest pain. She’s had some issues with her heart in the past. But could this be it? Could Grandma Betty really be having a heart attack? Your normal reaction would be to call 911, right? Not this time. Instead, you simply pull out your iPhone and use AliveCor’s ECG app to detect Grandma’s heart rhythm. And thankfully, her heart appears to be normal this time.

No, this isn’t a science fiction story. The iPhone ECG app is real…and very close to a FDA approval. In this interview with Dr. David Albert, we learn about his incredible journey in bringing the ECG app to market.


INTERVIEW HIGHLIGHTS WITH DR. DAVID ALBERT

  • The amazing story of how AliveCor’s iPhone ECG app helped save a man’s life while on an airplane!
  • What is the iPhone ECG app and how does it actually work?
  • Two disruptive features of the iPhone ECG app: Cloud and Cost
  • The roller coster ride Dr. Albert experienced in his pursuits to develop the ECG app.
  • Five key lessons you can learn from Dr. Albert’s experiences: 1) Be stubborn; 2) Use sounding boards; 3) Protect your IP; 4) Stay patient; and 5) Make a demo.
  • Where does Dr. Albert’s interest in gadgets come from? Hint: It’s personal.
  • Dr. Albert’s advice for ambitious doers: 1) Believe in your ideas; 2) Don’t be afraid to swim against the stream.
  • And much more!

DOWNLOAD THE INTERVIEW WITH DR. DAVID ALBERT

sponsored content

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.

PDF Transcript of Interview with Dr. David Albert – Founder of AliveCor

Original Audio Interview with Dr. David Albert – Founder of AliveCor


WHO IS DR. DAVID ALBERT?

David E. Albert, MD is a physician, inventor, and serial entrepreneur who has developed medical and other life-saving technologies and products over the last 30 years, turning a number of those innovations into tech startups. Today, he is a founder of three tech companies, InnovAlarm, Lifetone Technology and AliveCor. His previous startups include Corazonix Corp (sold to Arrhythmia Research Technology) and Data Critical (sold to GE). Dr. Albert left GE in 2004 as Chief Scientist of GE Cardiology to disrupt several new markets. His latest invention, the iPhone ECG, became a global sensation via a 4-minute YouTube Video in January around the Consumer Electronics Show and was featured on local media, ABC, CBS, CNN, and Fox News among many other media outlets. Dr Albert has 32 issued US patents, a large number pending, and several new “secret inventions” in development. He has authored or co-authored over 50 scientific abstracts and publications. Dr. Albert graduated with Honors from Harvard College and from Duke University Medical School.